CD44 and hepatocellular carcinoma: To determine whether NNMT enhanced HCC cell invasion via CD44, we knocked down CD44 in the NNMT‐overexpressing SMMC‐7721 cells and found that it significantly reversed the prometastatic effects of NNMT (Fig. 2E‐F).